Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patient
暂无分享,去创建一个
F. Grosso | A. Matucci | E. Maggi | A. Vultaggio | F. Nencini | S. Bormioli | L. Dies
[1] K. Kabashima,et al. The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus , 2017, Inflammation and regeneration.
[2] A. Giménez-Arnau,et al. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria , 2017, Allergy.
[3] E. Serrano-Candelas,et al. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments , 2016, Journal of immunology research.
[4] Yu-Chen Huang,et al. Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis. , 2016, The Journal of allergy and clinical immunology.
[5] Stephan Weidinger,et al. Atopic dermatitis , 2016, The Lancet.
[6] J. Schroeder,et al. Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization. , 2010, The Journal of allergy and clinical immunology.
[7] Stephen T Holgate,et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. , 2004, American journal of respiratory and critical care medicine.
[8] I I Lelis,et al. [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.